Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial.

Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D.

Arthritis Rheum. 2007 Dec;56(12):4142-50.

PMID:
18050206
[PubMed - indexed for MEDLINE]
Free Article
2.

[Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Hartung HP.

Nervenarzt. 2009 Dec;80(12):1462-72. doi: 10.1007/s00115-009-2838-6. Review. German.

PMID:
19779889
[PubMed - indexed for MEDLINE]
3.

Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis.

Bracewell C, Isaacs JD, Emery P, Ng WF.

Expert Opin Biol Ther. 2009 Jul;9(7):909-19. doi: 10.1517/14712590903033919. Review.

PMID:
19522556
[PubMed - indexed for MEDLINE]
4.

Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers.

Dörner T, Kinnman N, Tak PP.

Pharmacol Ther. 2010 Mar;125(3):464-75. doi: 10.1016/j.pharmthera.2010.01.001. Epub 2010 Jan 25. Review.

PMID:
20097226
[PubMed - indexed for MEDLINE]
5.

Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells.

Gatto B.

Curr Opin Investig Drugs. 2008 Nov;9(11):1216-27. Review.

PMID:
18951301
[PubMed - indexed for MEDLINE]
6.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
7.

High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.

Toubi E, Kessel A, Shoenfeld Y.

Hum Immunol. 2005 Apr;66(4):395-402. Review.

PMID:
15866703
[PubMed - indexed for MEDLINE]
8.

B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.

Looney RJ.

Drugs. 2010 Mar 26;70(5):529-40. doi: 10.2165/11535420-000000000-00000. Review.

PMID:
20297867
[PubMed - indexed for MEDLINE]
9.

Belimumab: in systemic lupus erythematosus.

Burness CB, McCormack PL.

Drugs. 2011 Dec 24;71(18):2435-44. doi: 10.2165/11208440-000000000-00000. Review.

PMID:
22141386
[PubMed - indexed for MEDLINE]
10.

Biologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development?

Stohl W.

Curr Rheumatol Rep. 2012 Aug;14(4):303-9. doi: 10.1007/s11926-012-0254-6. Review.

PMID:
22547203
[PubMed - indexed for MEDLINE]
11.

[Estrogen use in systemic lupus erythematosus].

Ketari S, Cherif O, Boussema F, Kochbati S, Ben Dhaou B, Rokbani L.

Gynecol Obstet Fertil. 2005 Oct;33(10):783-90. Review. French.

PMID:
16139552
[PubMed - indexed for MEDLINE]
12.

[New concepts for the therapy of systemic lupus erythematosus].

Spertini F.

Rev Med Suisse. 2007 Jan 17;3(94):98-102. Review. French.

PMID:
17354532
[PubMed - indexed for MEDLINE]
13.

The B cell in systemic lupus erythaematosus: a rational target for more effective therapy.

Driver CB, Ishimori M, Weisman MH.

Ann Rheum Dis. 2008 Oct;67(10):1374-81. Epub 2007 Aug 24. Review.

PMID:
17720723
[PubMed - indexed for MEDLINE]
14.

B cell depletion in systemic lupus erythematosus.

Leandro MJ, Ehrenstein MR.

Clin Med. 2007 Jan-Feb;7(1):57-9. Review. No abstract available.

PMID:
17348577
[PubMed - indexed for MEDLINE]
15.

Clinical and pharmacological experience with LJP-394.

Wallace DJ.

Expert Opin Investig Drugs. 2001 Jan;10(1):111-7. Review.

PMID:
11116284
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk